foxo4-dri human clinical trial Essential Peptide FOXO4-DRI Results: What to Expect

Nausea, headache, or flushing during early titration often dose- and rate-dependent

Class NNMT Inhibitor (Nicotinamide N-methyltransferase) Molecular Weight 193.2 Da (small molecule) Half-life Under investigation Purity 98% (HPLC) Form Powder Storage 20C, dry, protected from moisture Reconstitution DMSO or sterile water (partial solubility) Mechanism of action 5-Amino-1-methylquinolinium (5-Amino-1MQ) is a competitive inhibitor of NNMT an enzyme overexpressed in adipose tissue in obesity that converts nicotinamide to 1-methylnicotinamide while consuming SAM (S-adenosyl methionine)

After reconstitution with bacteriostatic water, refrigerate at 28C and use within 8 weeks

If you want optimal results, its essential to continue exercising, following a healthy diet, and making good lifestyle choices